I was a little bit surprised how quickly INCY was able to get SPA for Jakafi in pancreatic cancer ph3 trial. They said they got it in Nov 2013. Ph2 result was announced in late August, which means FDA didn't have any issue with proposed SPA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.